We expect our suppliers to deliver sustainable solutions while operating at high ethical standards and adhering to fair business practices. These suppliers are part of regional, national and international supply chains that are involved in the manufacturing process for Celgene therapies.
Celgene procurement follows a strategic sourcing process to identify the best suppliers and works with internal teams to ensure we obtain the best value from our suppliers in terms of quality, cost, service and delivery. We understand the value these businesses bring to Celgene and strongly encourage them to participate in our competitive bidding processes.
We appreciate the benefits of supplier diversity and consider small and diverse businesses to be an asset to our company and are continually seeking to develop long-term relationships with suppliers in the Small Business Administration (SBA) program, including:
- Small Businesses
- Minority Owned Businesses (Small/Large)
- Woman Owned Businesses (Small/Large)
- Small Disadvantaged Businesses (SDB)
- Historically Underutilized Business Zone Businesses
- Veteran and Service-Disabled Veteran Owned Businesses (Small/Large)
Celgene had business relations with 254 SBA suppliers in 2014, which represents about 3.8 percent of the suppliers used through US general sourcing. This also represents approximately 2.1 percent of the spend through US general sourcing (this does not include products and services related to our therapeutic manufacturing and development activities). Many of these suppliers represent more than one type of SBA category and further assist our goal of developing our business partnerships with diverse suppliers.
Celgene is a member of the Supplier Diversity Pharmaceutical Forum, a sub-committee of the Pharmaceutical Forum of the Institute for Supply Management. The Forum is a collaborative group of supply chain professionals with the goals of expanding supply base diversity in the pharmaceutical industry, developing best and next practices in supplier diversity and professional development.
Celgene joined the Customs-Trade Partnership Against Terrorism (C-TPAT) program as an importer in 2006. This voluntary initiative between US Customs and Border Protection (CBP) and private business aims to build relationships that strengthen the international supply chains and improve US border security.
In 2013, CBP selected Celgene to participate in a C-TPAT revalidation, which included an on-site review of our security procedures and the overall supply chain system for the company in both the US and in Europe.
In 2014, Celgene’s system attained the highest rating possible by the CBP for this revalidation. It was noted that management was engaged in supporting the C-TPAT program and was focused on monitoring and improving security procedures through periodic self-assessments.